One-stop Solution
Focus on single cell multiomics solutions to discover your program.
Highly Customizable
Make your program develop the way you want it to by customizing it using our platforms.
High-Speed Performance
You will never have to wait for too long with our 100% dedication.
Solutions
Break Out of the Limitations of Bulk
To better explore novel cancer treatments, it‘s critical to understand the tumor heterogeneity and the underlying mechanisms of tumor evolution, metastasis. Creative Biolabs provides single cell multiomics solutions and insights into tumor heterogeneity, cancer immunotherapies, cancer development and evolution, profilling tumor microenvironment, discovering novel cell types and states etc.
With recent major clinical success made by cancer immunotherapies, we increasingly appreciate the important roles of immunity including innate and addaptive immunities. Analysis of tumor infiltrated immune cells can provide insights into tumor diagnosis, prognosis and therapeutics. We are applying a single cell data driven approach to advance your immuno-oncology projects.
Microbiome plays a critical role in human physiology. To better understand how specific microbial clades interact with host cells to modulate cancer development, it's critical to dissect the human microbiome at the single-cell level. Moreover, discovering microbiome-directed immunity is another potential approach toward oncology precision medicine. We are applying a single cell data driven approach to advance your microbiome-oncology projects.
Comprehensive suit of single cell multiomics solutions provide possibilities to unravel the complexities of biological systems at the single cell level. With novel approaches to profile genetic, transcriptomic, epigenetic, spatial, proteomic information at the single cell level, our bioinformatics analysis scientists are dedicated to delivering accurate, visual, legible and easy-to-understand data to answer your specific scientific questions.
Applications
Discover the Difference
Characterizing Heterogeneity
Traditional average data analyzed across bulk populations can not illustrate various crucial biological phenomena. With state-of-the-art single cell approaches in genome, transcriptome, epigenome and proteome, it can provides novel and critical insights into heterogeneity.
Exploring Cancer Immunotherapies
Single-cell omics solution is highly promising due to its potential in analyzing integrated data from diverse omics platforms, providing multi-faceted insights into the interrelation of these omics layers on disease diagnosis, prognosis and therapeutics. Creative Biolabs offers single-cell omics solutions to help you explore novel cancer immunotherapies.
Unravelling Cancer Evolution
Understanding the evolution of tumor resistance, tumor metastasis, tumor clonal diversity is critical for the cancer discovery and treatment development. With senior scientists and multi-omics advanced platforms, Creative Biolabs provides comprehensive suite of single cell omics solutions for unraveling cancer evolution.
Monitoring of Immunity
The application of single cell genomics technologies has revolutionized the existing approach to explore an individual's immunity. Unfolding the functional diversity of immune cells and their coordinated reaction is key to understand the immune system. Single cell transcriptomics technologies open up a high-dimensional assessment of the transcriptional state of immune cells and have been successfully used to discover novel immune cell types, reveal hematopoietic lineages, identify gene modules regulating immune responses, and analyze lymphocyte antigen receptor diversity.
Profiling the Tumor Microenvironment
In the process of tumorigenesis, genetic heterogeneous cancer cell populations are generated. They evolved and interacted with cells in the tumor microenvironment, leading to host metabolic hijacking, immune escape, transfer to other body parts, and ultimately death. Profiling the tumor microenvironment with single-cell technology can provide valuable insights into the mechanisms of tumor progression and potential cancer immunotherapies.
